Skip to main content
Log in

Increased Granulysin Expression in Peripheral Blood Cells of Patients with Primary Biliary Cirrhosis and Its Clinical Implications

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Introduction

Granulysin is a cytotoxic molecule involved in cellular immune reactions.

Materials and methods

The levels of granulysin mRNA in the peripheral blood and serum granulysin of patients with primary biliary cirrhosis (PBC) were determined by quantitative polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The expression of granulysin mRNA and serum protein in PBC was increased compared to the controls.

Results

The expression of granulysin mRNA or serum protein showed close associations, respectively, with natural killer cell population in PBC patients. Serum granulysin was down-regulated by steroid and ursodeoxycholic therapy for PBC according to the improvement of severity of PBC. In addition, the expression of serum granulysin were related to serum total bilirubin and Mayo Clinic risk score. The serum granulysin reflected the cellular immune status of patients with PBC, and the expression correlated with the severity of PBC.

Conclusion

Therefore, there is a clinical benefit to monitoring granulysin as a biomarker of the prognosis of patients with PBC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Pena SV, Krensky AM. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol 1997;9:117–25.

    Article  PubMed  CAS  Google Scholar 

  2. Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM. The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med 1987;165:601–14.

    Article  PubMed  CAS  Google Scholar 

  3. Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM. Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 2005;174:5243–8.

    PubMed  CAS  Google Scholar 

  4. Kaspar AA, Okada S, Kumar J, Poulain FR, Drouvalakis KA, Kelekar A, et al. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J Immunol 2001;167:350–6.

    PubMed  CAS  Google Scholar 

  5. Krensky AM, Clayberger C. Granulysin: a novel host defense molecule. Am J Transplant 2005;5:1789–92.

    Article  PubMed  CAS  Google Scholar 

  6. Ogawa K, Takamori Y, Suzuki K, Nagasawa M, Takano S, Kasahara Y, et al. Granulysin in human serum as a marker of cell-mediated immunity. Eur J Immunol 2003;33:1925–33.

    Article  PubMed  CAS  Google Scholar 

  7. Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, Cho S, et al. T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001;7:174–9.

    Article  PubMed  CAS  Google Scholar 

  8. Saigusa S, Ichikura T, Tsujimoto H, Sugasawa H, Majima T, Kawarabayashi N, et al. Serum granulysin level as a novel prognostic marker in patients with gastric carcinoma. J Gastroenterol Hepatol 2007;22:1322–7.

    Article  PubMed  CAS  Google Scholar 

  9. Nagasawa M, Isoda T, Itoh S, Kajiwara M, Morio T, Shimizu N, et al. Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction. Am J Hematol 2006;81:340–8.

    Article  PubMed  CAS  Google Scholar 

  10. Sakai M, Ogawa K, Shiozaki A, Yoneda S, Sasaki Y, Nagata K, Saito S. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia. Clin Exp Immunol 2004;136:114–9.

    Article  PubMed  CAS  Google Scholar 

  11. He XS, Ansari AA, Ridgway WM, Coppel RL, Gershwin ME. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 2006;239:1–13.

    Article  PubMed  CAS  Google Scholar 

  12. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261–73.

    Article  PubMed  CAS  Google Scholar 

  13. Benhamou JP. Indications for liver transplantation in primary biliary cirrhosis. Hepatology 1994;20:11S–13S.

    PubMed  CAS  Google Scholar 

  14. Goudie BM, Burt AD, Macfarlane GJ, Boyle P, Gillis CR, MacSween RN, Watkinson G. Risk factors and prognosis in primary biliary cirrhosis. Am J Gastroenterol 1989;84:713–6.

    PubMed  CAS  Google Scholar 

  15. Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology 2000;31:1005–13.

    Article  PubMed  CAS  Google Scholar 

  16. Di Liberto D, Buccheri S, Caccamo N, Meraviglia S, Romano A, Di Carlo P, et al. Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy. Tuberculosis (Edinb) 2007;87:322–8.

    Article  CAS  Google Scholar 

  17. Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: model for decision making. Hepatology 1989;10:1–7.

    Article  PubMed  CAS  Google Scholar 

  18. Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002;109:1231–40.

    PubMed  CAS  Google Scholar 

  19. Latinovic-Golic S, Walch M, Sundstrom H, Dumrese C, Groscurth P, Ziegler U. Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes. BMC Immunol 2007;8:9.

    Article  PubMed  CAS  Google Scholar 

  20. Johansson S, Hall H, Berg L, Hoglund P. NK cells in autoimmune disease. Curr Top Microbiol Immunol 2006;298:259–77.

    Article  PubMed  CAS  Google Scholar 

  21. Okada C, Akbar SM, Horiike N, Onji M. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int 2005;25:595–603.

    Article  PubMed  CAS  Google Scholar 

  22. Panasiuk A, Prokopowicz D, Zak J. Peripheral blood T, B lymphocytes and NK cells in primary biliary cirrhosis. Rocz Akad Med Bialymst 2001;46:231–9.

    PubMed  CAS  Google Scholar 

  23. Musialik J, Petelenz M, Jastrzebski D, Ziora D, Kondera-Anasz Z, Mertas A, et al. Lymphocyte subsets in peripheral blood and bronchoalveolar lavage in patients with primary biliary cirrhosis. Med Sci Monit 2001;7(1):311–5.

    PubMed  Google Scholar 

  24. Chuang YH, Lian ZX, Tsuneyama K, Chiang BL, Ansari AA, Coppel RL, Eric Gershwin M. Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun 2006;26:232–40.

    Article  PubMed  CAS  Google Scholar 

  25. Fracchia M, Secreto P, Tabone M, Zaffino C, Pera A, Galatola G. Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination. Eur J Gastroenterol Hepatol 2000;12:463–8.

    Article  PubMed  CAS  Google Scholar 

  26. Clayberger C, Krensky AM. Granulysin. Curr Opin Immunol 2003;15:560–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Alan M Krensky (Stanford University School of Medicine) for giving us the antibodies, and we are also grateful to PEI Gang and KANG Jiuhong (Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences) for technical assistance. This study was supported by grant from National High-tech R & D Program (863 Program; 2006AA02Z496).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Cheng Qian, Anmei Deng or Renqian Zhong.

Additional information

Cheng Qian, Sunxiao Chen, and Dingkang Yao contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qian, C., Chen, S., Yao, D. et al. Increased Granulysin Expression in Peripheral Blood Cells of Patients with Primary Biliary Cirrhosis and Its Clinical Implications. J Clin Immunol 28, 520–527 (2008). https://doi.org/10.1007/s10875-008-9207-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-008-9207-2

Keywords

Navigation